Isolation, phylogenetic analysis and anti-infective activity screening of marine sponge-associated actinomycetes.
Terrestrial actinomycetes are noteworthy producers of a multitude of antibiotics, however the marine representatives are much less studied in this regard. In this study, 90 actinomycetes were isolated from 11 different species of marine sponges that had been collected from offshore Ras Mohamed (Egypt) and from Rovinj (Croatia). Phylogenetic characterization of the isolates based on 16S rRNA gene sequencing supported their assignment to 18 different actinomycete genera representing seven different suborders. Fourteen putatively novel species were identified based on sequence similarity values below 98.2% to other strains in the NCBI database. A putative new genus related to Rubrobacter was isolated on M1 agar that had been amended with sponge extract, thus highlighting the need for innovative cultivation protocols. Testing for anti-infective activities was performed against clinically relevant, Gram-positive (Enterococcus faecalis, Staphylococcus aureus) and Gram-negative (Escherichia coli, Pseudomonas aeruginosa) bacteria, fungi (Candida albicans) and human parasites (Leishmania major, Trypanosoma brucei). Bioactivities against these pathogens were documented for 10 actinomycete isolates. These results show a high diversity of actinomycetes associated with marine sponges as well as highlight their potential to produce anti-infective agents.
Abdelmohsen
Usama Ramadan
UR
Julius-von-Sachs-Institute for Biological Sciences, University of Würzburg, Julius-von-Sachs-Platz 3, 97082 Würzburg, Germany. Usama.Ramadan@biozentrum.uni-wuerzburg.de
Pimentel-Elardo
Sheila M
SM
Hanora
Amro
A
Radwan
Mona
M
Abou-El-Ela
Soad H
SH
Ahmed
Safwat
S
Hentschel
Ute
U
D039903:Actinobacteria / Q000737:chemistry / Q000145:classification / Q000235:genetics / Q000302:isolation & purification; D000818:Animals; D000890:Anti-Infective Agents / Q000302:isolation & purification / Q000494:pharmacology*; D001419:Bacteria / Q000187:drug effects*; D018320:Leishmania major / Q000187:drug effects; D008969:Molecular Sequence Data; D010802:Phylogeny; D011161:Porifera / Q000382:microbiology*; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D014346:Trypanosoma brucei brucei / Q000187:drug effects
D000890:Anti-Infective Agents; D012336:RNA, Ribosomal, 16S
J Appl Microbiol. 1998 Aug;85(2):195-210
9750292
Nature. 2008 Feb 21;451(7181):990-3
18288193
Nature. 2008 Feb 21;451(7181):898-9
18288175
Nucleic Acids Res. 2004 Feb 25;32(4):1363-71
14985472
Environ Microbiol. 2007 Nov;9(11):2756-64
17922759
Appl Environ Microbiol. 2007 Aug;73(16):5261-7
17586664
JAMA. 1996 Jan 17;275(3):189-93
8604170
Int J Syst Evol Microbiol. 2005 Sep;55(Pt 5):1759-1766
16166663
Science. 2000 Jan 21;287(5452):443-9
10642539
J Mar Biotechnol. 1998 Dec;6(4):233-236
9852617
J Bacteriol. 1958 Nov;76(5):457-63
13598702
Nat Chem Biol. 2006 Dec;2(12):666-73
17108984
J Nat Prod. 2000 May;63(5):621-6
10843572
Appl Environ Microbiol. 2006 Mar;72(3):2118-25
16517661
Antonie Van Leeuwenhoek. 2005 Jan;87(1):11-8
15726286
Nat Prod Rep. 2007 Feb;24(1):31-86
17268607
Microbiol Mol Biol Rev. 2007 Jun;71(2):295-347
17554047
Antimicrob Agents Chemother. 2002 May;46(5):1597-601
11959611
J Antibiot (Tokyo). 1980 Nov;33(11):1274-80
6894748
Mar Biotechnol (NY). 2010 Jun;12(3):350-60
19957096
Nature. 2004 Jul 8;430(6996):242-9
15241422
J Am Chem Soc. 2006 Jun 14;128(23):7486-91
16756302
Acta Trop. 1993 Dec;55(4):257-61
8147282
Antonie Van Leeuwenhoek. 2006 Aug;90(2):159-69
16871424
Antimicrob Agents Chemother. 2006 Jul;50(7):2439-47
16801424
Trends Microbiol. 2007 Nov;15(11):491-9
17997312
Appl Environ Microbiol. 2001 Jan;67(1):434-44
11133476
FEMS Microbiol Ecol. 2001 May;35(3):305-312
11311441
Extremophiles. 2006 Jun;10(3):181-9
16538400
Antonie Van Leeuwenhoek. 2005 Jan;87(1):29-36
15726288
Appl Environ Microbiol. 1985 Jan;49(1):83-90
16346712
Curr Opin Microbiol. 2006 Jun;9(3):245-51
16675289
J Antibiot (Tokyo). 1982 Apr;35(4):391-5
7096194
Environ Microbiol. 2005 Apr;7(4):509-18
15816928
Environ Microbiol. 2007 Jun;9(6):1363-75
17504474
Appl Environ Microbiol. 2005 Dec;71(12):7724-36
16332745
Appl Environ Microbiol. 2002 Oct;68(10):5005-11
12324350
Arch Pharm Res. 1998 Dec;21(6):729-33
9868546
FEMS Microbiol Ecol. 2006 Feb;55(2):167-77
16420625
Appl Environ Microbiol. 2002 Sep;68(9):4431-40
12200297
Microb Ecol. 2000 Aug;40(2):139-147
11029082
Antonie Van Leeuwenhoek. 2008 Mar;93(3):241-8
17717723
Appl Environ Microbiol. 1985 Jan;49(1):1-7
3883894